Nitrogen

Description

Nitrogen, compressed, is classified under NF UN 1066. It is a high-pressure gas that poses a risk of rapid suffocation if not handled properly. It is essential to store and utilize this gas in well-ventilated areas and to employ equipment that is rated for the cylinder pressure. The valve should be closed when the gas is not in use or when the cylinder is empty. Usage must comply with the guidelines provided in the supplier's Material Safety Data Sheet.

Uses and Indications

Nitrogen compressed is indicated for use as a high-pressure gas. It is important to note that this gas can cause rapid suffocation if not handled properly.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with nitrogen compressed as per the available data.

Dosage and Administration

Administration of nitrogen is indicated for use only by or under the supervision of a licensed practitioner experienced in its use and administration, as it may pose hazards or be contraindicated in certain situations.

The route of administration is via respiratory inhalation. The active ingredient is nitrogen, with a strength of 99 L in 100 L. It is essential that healthcare professionals ensure proper handling and administration techniques to mitigate risks associated with nitrogen inhalation.

Contraindications

Administration of nitrogen is contraindicated due to potential hazards associated with its use. It is essential that nitrogen is only administered by or under the supervision of a licensed practitioner experienced in its use and administration.

Warnings and Precautions

Administration of nitrogen may pose significant risks and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of nitrogen. The practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration, as well as the associated hazards, contraindications, and potential side effects.

Healthcare professionals are advised to exercise caution and ensure that all necessary precautions are taken prior to administration. This includes a thorough assessment of the patient's medical history and current health status to identify any potential contraindications. Regular monitoring of the patient during and after administration is essential to mitigate risks and manage any adverse effects that may arise.

Side Effects

Administration of nitrogen may pose significant risks and is contraindicated in certain situations. It is imperative that nitrogen is used solely by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, and potential side effects.

Due to the potential hazards involved, careful consideration and adherence to precautions are essential to ensure patient safety during the administration of nitrogen.

Drug Interactions

The administration of nitrogen may pose significant risks and is contraindicated in certain situations. It is essential that nitrogen is used exclusively by or under the supervision of a licensed practitioner who possesses expertise in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Due to the potential hazards involved, careful consideration and monitoring are advised when nitrogen is administered. Practitioners should ensure that they are familiar with the specific clinical context and patient conditions that may affect the safe use of nitrogen.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of nitrogen in pediatric patients may pose hazards or be contraindicated. It is essential that nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The administration of nitrogen during pregnancy may pose potential risks and is considered hazardous or contraindicated. Pregnant patients should only receive nitrogen under the supervision of a licensed practitioner who is experienced in its use and administration. Healthcare professionals are advised to carefully evaluate the necessity and potential fetal impacts before considering nitrogen therapy in pregnant patients.

Lactation

The safety of nitrogen gas during lactation has not been established. Caution should be exercised when administering this product to nursing mothers. There is a potential for excretion in breast milk; therefore, the risks and benefits should be carefully considered before use in breastfeeding women.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care and symptomatic treatment as necessary. This may include monitoring vital signs, providing respiratory support, and administering intravenous fluids if indicated.

Additionally, healthcare professionals should consult local poison control centers or relevant toxicology resources for guidance on specific management protocols tailored to the substance involved.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients about the potential hazards associated with high-pressure gas, emphasizing that it can cause rapid suffocation. Patients should be instructed to store and use the gas in well-ventilated areas and to utilize equipment that is rated for cylinder pressure. It is important to remind patients to close the valve when the gas is not in use and when the cylinder is empty. They should also be encouraged to follow the guidelines outlined in the supplier's Material Safety Data Sheet.

In the event of inhalation, healthcare providers should instruct patients to seek fresh air immediately. If the patient is not breathing, they should be advised to perform artificial respiration. If breathing difficulties arise, supplemental oxygen should be administered, and a physician should be contacted without delay.

Providers must communicate that the administration of nitrogen may pose hazards or be contraindicated. It is crucial that nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Patients should be made aware that the practitioner should be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Storage and Handling

The product is supplied in a manner that ensures safe handling and storage. It is essential to store and use the product in an area with adequate ventilation to prevent the accumulation of potentially harmful gases. Equipment utilized for handling the product must be rated for cylinder pressure to ensure safety during use.

When the product is not in use or when the cylinder is empty, it is crucial to close the valve to prevent any accidental release of contents. Additionally, users are advised to follow the guidelines outlined in the supplier's Material Safety Data Sheet (MSDS) to ensure proper handling and safety measures are adhered to at all times.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Capweld Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)